Gene Symbol | Gene ID | Gene Info |
---|---|---|
Etv1
|
ENSMUSG00000004151.10 | ets variant 1 |
Etv5
|
ENSMUSG00000013089.9 | ets variant 5 |
Gabpa
|
ENSMUSG00000008976.10 | GA repeat binding protein, alpha |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_38778516_38778828 | Etv1 | 708 | 0.720451 | 0.93 | 7.6e-03 | Click! |
chr12_38779922_38780090 | Etv1 | 76 | 0.977375 | -0.72 | 1.1e-01 | Click! |
chr12_38780176_38780341 | Etv1 | 26 | 0.981374 | -0.64 | 1.8e-01 | Click! |
chr12_38788689_38788866 | Etv1 | 5268 | 0.241992 | 0.57 | 2.3e-01 | Click! |
chr12_38780430_38780581 | Etv1 | 156 | 0.963276 | -0.56 | 2.5e-01 | Click! |
chr16_22439730_22439912 | Etv5 | 102 | 0.968532 | 0.95 | 3.1e-03 | Click! |
chr16_22440534_22440713 | Etv5 | 904 | 0.586189 | -0.92 | 1.0e-02 | Click! |
chr16_22452275_22452453 | Etv5 | 12645 | 0.169029 | 0.89 | 1.9e-02 | Click! |
chr16_22436162_22436319 | Etv5 | 274 | 0.914442 | 0.67 | 1.4e-01 | Click! |
chr16_22439551_22439702 | Etv5 | 10 | 0.978141 | 0.57 | 2.3e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_20241060_20241211 | 6.21 |
Map7 |
microtubule-associated protein 7 |
11340 |
0.14 |
chr2_152686932_152687103 | 4.40 |
Mcts2 |
malignant T cell amplified sequence 2 |
18 |
0.95 |
chr2_24311684_24311860 | 4.35 |
Gm13411 |
predicted gene 13411 |
10652 |
0.12 |
chr3_84582502_84582696 | 4.21 |
Arfip1 |
ADP-ribosylation factor interacting protein 1 |
26 |
0.97 |
chr10_81606036_81606372 | 4.13 |
BC025920 |
cDNA sequence BC025920 |
66 |
0.93 |
chr10_118854799_118854964 | 4.06 |
4932442E05Rik |
RIKEN cDNA 4932442E05 gene |
5945 |
0.14 |
chr4_143412810_143412965 | 3.68 |
Pramef8 |
PRAME family member 8 |
85 |
0.95 |
chr10_99384294_99384806 | 3.62 |
B530045E10Rik |
RIKEN cDNA B530045E10 gene |
18240 |
0.17 |
chr8_70777137_70777343 | 3.57 |
2010320M18Rik |
RIKEN cDNA 2010320M18 gene |
425 |
0.43 |
chr1_119289922_119290107 | 3.55 |
Gm29456 |
predicted gene 29456 |
36819 |
0.14 |
chr17_29465506_29465692 | 3.47 |
Gm26885 |
predicted gene, 26885 |
399 |
0.53 |
chr18_81199291_81199673 | 3.40 |
4930594M17Rik |
RIKEN cDNA 4930594M17 gene |
36584 |
0.17 |
chr1_39731626_39731803 | 3.40 |
Rfx8 |
regulatory factor X 8 |
10717 |
0.2 |
chr12_110460715_110460866 | 3.39 |
Ppp2r5c |
protein phosphatase 2, regulatory subunit B', gamma |
13483 |
0.16 |
chr8_114815443_114815594 | 3.38 |
Wwox |
WW domain-containing oxidoreductase |
103351 |
0.07 |
chr2_129129602_129129765 | 3.32 |
Chchd5 |
coiled-coil-helix-coiled-coil-helix domain containing 5 |
17 |
0.96 |
chr8_11272313_11272503 | 3.17 |
Col4a1 |
collagen, type IV, alpha 1 |
7248 |
0.18 |
chr7_45062296_45062458 | 3.17 |
Prrg2 |
proline-rich Gla (G-carboxyglutamic acid) polypeptide 2 |
26 |
0.5 |
chr2_148443567_148443727 | 3.16 |
Cd93 |
CD93 antigen |
84 |
0.97 |
chr19_8920279_8920446 | 3.09 |
B3gat3 |
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) |
12 |
0.91 |
chr19_53943933_53944326 | 3.07 |
Bbip1 |
BBSome interacting protein 1 |
51 |
0.67 |
chr9_26923072_26923237 | 3.05 |
Gm1110 |
predicted gene 1110 |
43 |
0.97 |
chr19_28677852_28678003 | 3.05 |
D930032P07Rik |
RIKEN cDNA D930032P07 gene |
297 |
0.78 |
chr1_181345585_181345736 | 3.03 |
Cnih3 |
cornichon family AMPA receptor auxiliary protein 3 |
6968 |
0.18 |
chr11_30263761_30263925 | 3.00 |
Sptbn1 |
spectrin beta, non-erythrocytic 1 |
3371 |
0.26 |
chr4_148448330_148448496 | 2.98 |
Mtor |
mechanistic target of rapamycin kinase |
198 |
0.91 |
chr16_77569572_77569736 | 2.95 |
Gm37606 |
predicted gene, 37606 |
8004 |
0.11 |
chr11_109559331_109559545 | 2.93 |
Arsg |
arylsulfatase G |
15684 |
0.15 |
chr1_194652069_194652379 | 2.92 |
Gm37783 |
predicted gene, 37783 |
1905 |
0.29 |
chr8_91134020_91134367 | 2.92 |
Aktip |
thymoma viral proto-oncogene 1 interacting protein |
166 |
0.92 |
chrX_51018786_51019139 | 2.91 |
Rap2c |
RAP2C, member of RAS oncogene family |
944 |
0.61 |
chr12_24463539_24463734 | 2.91 |
Gm16372 |
predicted pseudogene 16372 |
30020 |
0.14 |
chr13_14039579_14039741 | 2.90 |
Tbce |
tubulin-specific chaperone E |
22 |
0.96 |
chr12_27823461_27823643 | 2.87 |
Gm45941 |
predicted gene, 45941 |
122490 |
0.06 |
chr9_44568060_44568211 | 2.87 |
Cxcr5 |
chemokine (C-X-C motif) receptor 5 |
6258 |
0.08 |
chr14_70153748_70153912 | 2.87 |
Ccar2 |
cell cycle activator and apoptosis regulator 2 |
19 |
0.96 |
chr3_121395917_121396068 | 2.87 |
Gm5711 |
predicted gene 5711 |
15313 |
0.14 |
chr4_95354053_95354288 | 2.86 |
Gm29064 |
predicted gene 29064 |
48620 |
0.15 |
chr2_131509876_131510027 | 2.85 |
Smox |
spermine oxidase |
999 |
0.53 |
chr13_40898236_40898396 | 2.83 |
Gcnt2 |
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme |
11123 |
0.1 |
chr5_76013943_76014156 | 2.77 |
Gm24738 |
predicted gene, 24738 |
7608 |
0.17 |
chr17_24073456_24073620 | 2.76 |
Kctd5 |
potassium channel tetramerisation domain containing 5 |
53 |
0.94 |
chr19_36133150_36133315 | 2.76 |
Ankrd1 |
ankyrin repeat domain 1 (cardiac muscle) |
13133 |
0.19 |
chr17_29502998_29503149 | 2.75 |
Pim1 |
proviral integration site 1 |
9666 |
0.1 |
chr8_83657002_83657190 | 2.73 |
Gipc1 |
GIPC PDZ domain containing family, member 1 |
4398 |
0.12 |
chr7_44553917_44554074 | 2.73 |
Nr1h2 |
nuclear receptor subfamily 1, group H, member 2 |
44 |
0.92 |
chr17_22867078_22867262 | 2.71 |
Zfp945 |
zinc finger protein 945 |
36 |
0.97 |
chr1_88635717_88635891 | 2.70 |
Gm38130 |
predicted gene, 38130 |
17281 |
0.16 |
chr5_129260831_129260994 | 2.70 |
Gm43001 |
predicted gene 43001 |
102650 |
0.07 |
chr13_40898039_40898200 | 2.70 |
Gcnt2 |
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme |
10926 |
0.1 |
chr13_21362713_21362885 | 2.69 |
Zscan12 |
zinc finger and SCAN domain containing 12 |
21 |
0.94 |
chr19_8941828_8942014 | 2.69 |
Mta2 |
metastasis-associated gene family, member 2 |
46 |
0.9 |
chr11_67052492_67052675 | 2.68 |
Adprm |
ADP-ribose/CDP-alcohol diphosphatase, manganese dependent |
2 |
0.56 |
chr11_98767399_98767584 | 2.68 |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
2935 |
0.14 |
chr2_26342721_26342891 | 2.68 |
Gpsm1 |
G-protein signalling modulator 1 (AGS3-like, C. elegans) |
517 |
0.6 |
chr15_66934384_66934535 | 2.68 |
Ndrg1 |
N-myc downstream regulated gene 1 |
10 |
0.97 |
chr17_33955699_33955862 | 2.67 |
Vps52 |
VPS52 GARP complex subunit |
32 |
0.55 |
chr9_46272980_46273140 | 2.67 |
Zpr1 |
ZPR1 zinc finger |
4 |
0.94 |
chr4_42165784_42165944 | 2.67 |
Gm13305 |
predicted gene 13305 |
1128 |
0.27 |
chr4_42662941_42663103 | 2.64 |
Il11ra2 |
interleukin 11 receptor, alpha chain 2 |
1129 |
0.37 |
chr14_22269831_22270192 | 2.63 |
Lrmda |
leucine rich melanocyte differentiation associated |
40154 |
0.2 |
chr7_16399798_16399999 | 2.60 |
Zc3h4 |
zinc finger CCCH-type containing 4 |
1012 |
0.35 |
chr2_27540118_27540305 | 2.59 |
Gm13421 |
predicted gene 13421 |
215 |
0.57 |
chr11_101442076_101442407 | 2.58 |
Rpl27 |
ribosomal protein L27 |
57 |
0.92 |
chr12_4234255_4234429 | 2.56 |
Cenpo |
centromere protein O |
48 |
0.8 |
chr3_95016159_95016328 | 2.56 |
4930481B07Rik |
RIKEN cDNA 4930481B07 gene |
6 |
0.91 |
chr12_25132357_25132520 | 2.56 |
Gm17746 |
predicted gene, 17746 |
3264 |
0.21 |
chr7_24610415_24610850 | 2.55 |
Phldb3 |
pleckstrin homology like domain, family B, member 3 |
131 |
0.91 |
chr17_84074449_84074742 | 2.54 |
4933433H22Rik |
RIKEN cDNA 4933433H22 gene |
4065 |
0.18 |
chr17_67512799_67512950 | 2.54 |
Gm36201 |
predicted gene, 36201 |
116458 |
0.06 |
chr5_146912263_146912599 | 2.53 |
Gtf3a |
general transcription factor III A |
36226 |
0.12 |
chr11_103223555_103223709 | 2.53 |
Map3k14 |
mitogen-activated protein kinase kinase kinase 14 |
1785 |
0.22 |
chr1_93801909_93802071 | 2.52 |
Dtymk |
deoxythymidylate kinase |
56 |
0.95 |
chr1_64374852_64375011 | 2.51 |
Gm25748 |
predicted gene, 25748 |
21403 |
0.21 |
chr10_105311004_105311282 | 2.49 |
Gm48206 |
predicted gene, 48206 |
29106 |
0.18 |
chr1_167356546_167356902 | 2.49 |
Aldh9a1 |
aldehyde dehydrogenase 9, subfamily A1 |
6412 |
0.13 |
chr10_10457121_10457304 | 2.48 |
Gm48326 |
predicted gene, 48326 |
8322 |
0.2 |
chr2_169997535_169997686 | 2.48 |
AY702102 |
cDNA sequence AY702102 |
34423 |
0.21 |
chr2_35496007_35496180 | 2.47 |
Gm13445 |
predicted gene 13445 |
4574 |
0.15 |
chr2_157082117_157082275 | 2.47 |
Soga1 |
suppressor of glucose, autophagy associated 1 |
2942 |
0.19 |
chr15_101336869_101337081 | 2.46 |
Gm35853 |
predicted gene, 35853 |
14087 |
0.09 |
chr12_21526957_21527150 | 2.46 |
Gm19196 |
predicted gene, 19196 |
16254 |
0.22 |
chr4_135972578_135972738 | 2.44 |
Lypla2 |
lysophospholipase 2 |
32 |
0.95 |
chr7_43313215_43313406 | 2.44 |
Zfp715 |
zinc finger protein 715 |
16 |
0.96 |
chr17_35241635_35241803 | 2.43 |
Ddx39b |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B |
27 |
0.88 |
chr10_127743128_127743283 | 2.42 |
Zbtb39 |
zinc finger and BTB domain containing 39 |
3667 |
0.1 |
chr11_55406169_55406386 | 2.41 |
Sparc |
secreted acidic cysteine rich glycoprotein |
4112 |
0.19 |
chr18_69782032_69782386 | 2.41 |
Tcf4 |
transcription factor 4 |
99829 |
0.07 |
chr5_114806082_114806287 | 2.39 |
Ankrd13a |
ankyrin repeat domain 13a |
6613 |
0.09 |
chr1_185587723_185587874 | 2.39 |
5033404E19Rik |
RIKEN cDNA 5033404E19 gene |
90410 |
0.07 |
chr9_124424078_124424238 | 2.38 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
4 |
0.97 |
chr10_119063130_119063294 | 2.38 |
Gm33677 |
predicted gene, 33677 |
12713 |
0.14 |
chr13_49195695_49195846 | 2.37 |
Ninj1 |
ninjurin 1 |
5474 |
0.19 |
chr9_44130118_44130295 | 2.37 |
Mcam |
melanoma cell adhesion molecule |
4263 |
0.07 |
chr11_7203353_7203538 | 2.36 |
Igfbp1 |
insulin-like growth factor binding protein 1 |
5663 |
0.18 |
chr6_113326732_113326898 | 2.35 |
Gm15492 |
predicted gene 15492 |
68 |
0.61 |
chr1_72854260_72854454 | 2.34 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
5658 |
0.23 |
chr17_87157811_87157968 | 2.34 |
Gm22346 |
predicted gene, 22346 |
26336 |
0.13 |
chr6_137145657_137145998 | 2.34 |
4930480K02Rik |
RIKEN cDNA 4930480K02 gene |
1102 |
0.54 |
chr7_132245773_132246102 | 2.32 |
Chst15 |
carbohydrate sulfotransferase 15 |
32688 |
0.14 |
chr2_170208965_170209511 | 2.31 |
Zfp217 |
zinc finger protein 217 |
61135 |
0.12 |
chr10_85354450_85354601 | 2.31 |
Gm25281 |
predicted gene, 25281 |
20624 |
0.16 |
chr13_49242852_49243003 | 2.30 |
Susd3 |
sushi domain containing 3 |
27 |
0.98 |
chr11_59885393_59885544 | 2.29 |
Gm12714 |
predicted gene 12714 |
12906 |
0.11 |
chr12_69299371_69299530 | 2.29 |
Klhdc2 |
kelch domain containing 2 |
2695 |
0.15 |
chr19_44008793_44009176 | 2.29 |
Cyp2c23 |
cytochrome P450, family 2, subfamily c, polypeptide 23 |
20215 |
0.13 |
chr14_65890699_65890883 | 2.29 |
Ccdc25 |
coiled-coil domain containing 25 |
53431 |
0.1 |
chr13_23684749_23684907 | 2.29 |
H2bc4 |
H2B clustered histone 4 |
629 |
0.29 |
chr7_68606375_68606542 | 2.28 |
Gm44887 |
predicted gene 44887 |
7604 |
0.22 |
chr8_105504683_105504849 | 2.27 |
Gm8838 |
predicted gene 8838 |
1360 |
0.25 |
chr15_98484617_98484776 | 2.27 |
Lalba |
lactalbumin, alpha |
1975 |
0.14 |
chr5_105732097_105732253 | 2.26 |
Lrrc8d |
leucine rich repeat containing 8D |
55 |
0.98 |
chr12_85348430_85348753 | 2.25 |
Tmed10 |
transmembrane p24 trafficking protein 10 |
2329 |
0.17 |
chr1_74588142_74588305 | 2.25 |
Zfp142 |
zinc finger protein 142 |
23 |
0.52 |
chr5_129887229_129887536 | 2.24 |
Chchd2 |
coiled-coil-helix-coiled-coil-helix domain containing 2 |
88 |
0.93 |
chr19_38134156_38134336 | 2.24 |
Pde6c |
phosphodiesterase 6C, cGMP specific, cone, alpha prime |
1300 |
0.38 |
chr13_56678467_56678641 | 2.24 |
Smad5 |
SMAD family member 5 |
24456 |
0.18 |
chr17_33909179_33909514 | 2.23 |
BC051226 |
cDNA sequence BC051226 |
29 |
0.51 |
chr11_83942005_83942189 | 2.23 |
Ddx52 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 52 |
35 |
0.98 |
chr5_65095235_65095408 | 2.22 |
Tmem156 |
transmembrane protein 156 |
3189 |
0.21 |
chr10_62506271_62506458 | 2.22 |
Srgn |
serglycin |
1391 |
0.34 |
chr15_95799780_95799936 | 2.22 |
Ano6 |
anoctamin 6 |
864 |
0.47 |
chr9_64050138_64050305 | 2.22 |
Gm25606 |
predicted gene, 25606 |
1725 |
0.26 |
chr9_56418996_56419161 | 2.22 |
Hmg20a |
high mobility group 20A |
248 |
0.83 |
chr5_148741720_148741892 | 2.21 |
2210417A02Rik |
RIKEN cDNA 2210417A02 gene |
34 |
0.97 |
chr12_21135891_21136175 | 2.20 |
Asap2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
24079 |
0.18 |
chr1_189006324_189006498 | 2.20 |
Kctd3 |
potassium channel tetramerisation domain containing 3 |
1417 |
0.48 |
chr10_86705679_86705859 | 2.20 |
Ttc41 |
tetratricopeptide repeat domain 41 |
42 |
0.65 |
chr11_55468108_55468290 | 2.20 |
G3bp1 |
GTPase activating protein (SH3 domain) binding protein 1 |
1486 |
0.25 |
chr17_47295314_47295504 | 2.19 |
Trerf1 |
transcriptional regulating factor 1 |
1340 |
0.4 |
chr1_172082674_172082831 | 2.19 |
Ncstn |
nicastrin |
43 |
0.5 |
chr2_114175267_114175427 | 2.18 |
Aqr |
aquarius |
8 |
0.98 |
chr6_125008873_125009028 | 2.18 |
Zfp384 |
zinc finger protein 384 |
195 |
0.86 |
chr15_10485923_10486083 | 2.18 |
Rad1 |
RAD1 checkpoint DNA exonuclease |
15 |
0.52 |
chr1_180354252_180354425 | 2.16 |
Gm37033 |
predicted gene, 37033 |
3311 |
0.17 |
chr11_100619600_100619765 | 2.16 |
Dnajc7 |
DnaJ heat shock protein family (Hsp40) member C7 |
23 |
0.87 |
chr18_55037289_55037448 | 2.16 |
Gm4221 |
predicted gene 4221 |
20217 |
0.17 |
chr7_105640345_105640514 | 2.16 |
Arfip2 |
ADP-ribosylation factor interacting protein 2 |
13 |
0.38 |
chr10_10396185_10396349 | 2.16 |
Adgb |
androglobin |
15477 |
0.2 |
chrX_105070092_105070260 | 2.16 |
5530601H04Rik |
RIKEN cDNA 5530601H04 gene |
52 |
0.97 |
chr17_57247789_57247957 | 2.16 |
Gpr108 |
G protein-coupled receptor 108 |
184 |
0.89 |
chr17_58480911_58481322 | 2.15 |
Gm49848 |
predicted gene, 49848 |
18791 |
0.25 |
chr6_59185430_59185581 | 2.14 |
Gm43905 |
predicted gene, 43905 |
7748 |
0.22 |
chr10_7835124_7835295 | 2.14 |
Mir5104 |
microRNA 5104 |
1172 |
0.33 |
chr3_36854068_36854318 | 2.14 |
4932438A13Rik |
RIKEN cDNA 4932438A13 gene |
8911 |
0.21 |
chr19_42610535_42610705 | 2.12 |
Loxl4 |
lysyl oxidase-like 4 |
2089 |
0.31 |
chr17_5794541_5794694 | 2.12 |
3300005D01Rik |
RIKEN cDNA 3300005D01 gene |
4040 |
0.19 |
chr8_11348698_11348849 | 2.12 |
Col4a1 |
collagen, type IV, alpha 1 |
35947 |
0.12 |
chr17_46621404_46621583 | 2.12 |
Ptk7 |
PTK7 protein tyrosine kinase 7 |
8011 |
0.1 |
chr12_80644107_80644265 | 2.11 |
Slc39a9 |
solute carrier family 39 (zinc transporter), member 9 |
40 |
0.52 |
chr5_8849350_8849972 | 2.11 |
Abcb1b |
ATP-binding cassette, sub-family B (MDR/TAP), member 1B |
328 |
0.86 |
chr15_75593070_75593251 | 2.11 |
Gpihbp1 |
GPI-anchored HDL-binding protein 1 |
3468 |
0.15 |
chr8_31150173_31150334 | 2.11 |
Tti2 |
TELO2 interacting protein 2 |
62 |
0.78 |
chr11_52268525_52268676 | 2.10 |
Tcf7 |
transcription factor 7, T cell specific |
6277 |
0.14 |
chr2_116972214_116972407 | 2.10 |
Gm29340 |
predicted gene 29340 |
4118 |
0.21 |
chr4_136090324_136090475 | 2.10 |
Gm13009 |
predicted gene 13009 |
15427 |
0.12 |
chr4_124714667_124714827 | 2.09 |
Sf3a3 |
splicing factor 3a, subunit 3 |
29 |
0.94 |
chr12_25266835_25267067 | 2.09 |
Gm19340 |
predicted gene, 19340 |
15644 |
0.18 |
chr2_135259291_135259442 | 2.09 |
Plcb1 |
phospholipase C, beta 1 |
10193 |
0.27 |
chr8_70634514_70634904 | 2.08 |
Gdf15 |
growth differentiation factor 15 |
2253 |
0.14 |
chr4_41124315_41124469 | 2.08 |
Nol6 |
nucleolar protein family 6 (RNA-associated) |
63 |
0.95 |
chr10_40246983_40247188 | 2.08 |
Rpf2 |
ribosome production factor 2 homolog |
49 |
0.95 |
chr2_119311583_119311839 | 2.08 |
Gm14207 |
predicted gene 14207 |
13832 |
0.1 |
chr16_11520908_11521091 | 2.08 |
Gm15897 |
predicted gene 15897 |
24693 |
0.22 |
chr12_84190226_84190393 | 2.08 |
Gm19327 |
predicted gene, 19327 |
2503 |
0.16 |
chr5_145280362_145280523 | 2.07 |
Zscan25 |
zinc finger and SCAN domain containing 25 |
58 |
0.96 |
chr9_7184329_7184534 | 2.07 |
Dync2h1 |
dynein cytoplasmic 2 heavy chain 1 |
15 |
0.57 |
chr2_84678032_84678386 | 2.07 |
Tmx2 |
thioredoxin-related transmembrane protein 2 |
91 |
0.45 |
chr7_141462099_141462283 | 2.07 |
Cracr2b |
calcium release activated channel regulator 2B |
231 |
0.77 |
chr1_157081558_157081731 | 2.07 |
Tex35 |
testis expressed 35 |
26744 |
0.13 |
chr19_25207714_25207893 | 2.06 |
Kank1 |
KN motif and ankyrin repeat domains 1 |
29172 |
0.17 |
chr1_94035316_94035618 | 2.06 |
Neu4 |
sialidase 4 |
14974 |
0.16 |
chr11_94347313_94347820 | 2.05 |
Abcc3 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
3620 |
0.18 |
chr8_72475167_72475323 | 2.05 |
Cherp |
calcium homeostasis endoplasmic reticulum protein |
19 |
0.95 |
chr5_143758154_143758320 | 2.05 |
D130017N08Rik |
RIKEN cDNA D130017N08 gene |
117 |
0.96 |
chr10_84577349_84577529 | 2.04 |
Tcp11l2 |
t-complex 11 (mouse) like 2 |
542 |
0.69 |
chr11_54413058_54413209 | 2.04 |
Gm12225 |
predicted gene 12225 |
8993 |
0.13 |
chr1_137074836_137075091 | 2.03 |
Gm23763 |
predicted gene, 23763 |
84693 |
0.09 |
chr6_48708145_48708369 | 2.03 |
Gimap6 |
GTPase, IMAP family member 6 |
32 |
0.93 |
chr16_95449403_95449694 | 2.03 |
Erg |
ETS transcription factor |
9697 |
0.27 |
chr1_87213827_87213985 | 2.02 |
Eif4e2 |
eukaryotic translation initiation factor 4E member 2 |
8 |
0.96 |
chr6_55275129_55275288 | 2.02 |
Mindy4 |
MINDY lysine 48 deubiquitinase 4 |
2947 |
0.23 |
chr5_34501653_34501804 | 2.02 |
Tnip2 |
TNFAIP3 interacting protein 2 |
110 |
0.93 |
chr10_123588527_123588968 | 2.01 |
Gm19169 |
predicted gene, 19169 |
5159 |
0.33 |
chr11_115641190_115641341 | 2.01 |
Slc25a19 |
solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19 |
12970 |
0.09 |
chr7_140772355_140773139 | 2.01 |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
8266 |
0.09 |
chr13_60358666_60358878 | 2.01 |
Gm10779 |
predicted gene 10779 |
27323 |
0.17 |
chr9_107628752_107629042 | 2.01 |
Gnai2 |
guanine nucleotide binding protein (G protein), alpha inhibiting 2 |
2291 |
0.11 |
chr6_115971312_115971488 | 2.01 |
Plxnd1 |
plexin D1 |
1974 |
0.25 |
chr7_101896245_101896404 | 2.00 |
Anapc15 |
anaphase promoting complex C subunit 15 |
16 |
0.94 |
chr7_69074762_69075237 | 2.00 |
Gm44691 |
predicted gene 44691 |
85595 |
0.09 |
chr13_107616531_107616706 | 1.99 |
Gm32090 |
predicted gene, 32090 |
3769 |
0.28 |
chr7_80864931_80865166 | 1.99 |
Zscan2 |
zinc finger and SCAN domain containing 2 |
2152 |
0.22 |
chr14_26637897_26638072 | 1.99 |
Arf4 |
ADP-ribosylation factor 4 |
90 |
0.65 |
chr2_69849294_69849463 | 1.99 |
Ssb |
Sjogren syndrome antigen B |
12184 |
0.11 |
chr17_74528383_74528548 | 1.99 |
Birc6 |
baculoviral IAP repeat-containing 6 |
3 |
0.86 |
chr6_48597775_48597962 | 1.99 |
Repin1 |
replication initiator 1 |
3549 |
0.08 |
chr17_86384670_86384861 | 1.98 |
2010106C02Rik |
RIKEN cDNA 2010106C02 gene |
97587 |
0.07 |
chr12_100168721_100168880 | 1.98 |
Nrde2 |
nrde-2 necessary for RNA interference, domain containing |
9147 |
0.13 |
chr10_51794643_51794832 | 1.98 |
Gm47614 |
predicted gene, 47614 |
7796 |
0.18 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.2 | 3.5 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
1.2 | 3.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.1 | 3.4 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
1.1 | 1.1 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
1.1 | 3.2 | GO:0030242 | pexophagy(GO:0030242) |
1.1 | 1.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.0 | 3.1 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
1.0 | 2.9 | GO:0030576 | Cajal body organization(GO:0030576) |
1.0 | 3.9 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.9 | 3.8 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.9 | 7.9 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.8 | 3.3 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.8 | 3.3 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.8 | 2.4 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.8 | 3.2 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.8 | 2.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.8 | 0.8 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.8 | 3.0 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.7 | 2.2 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.7 | 4.9 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.7 | 3.5 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.7 | 2.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.7 | 2.0 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.7 | 2.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.7 | 2.0 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.7 | 3.3 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.7 | 2.0 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.7 | 2.0 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.6 | 1.9 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.6 | 3.9 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.6 | 1.9 | GO:0015817 | histidine transport(GO:0015817) |
0.6 | 0.6 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.6 | 1.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.6 | 2.5 | GO:0051031 | tRNA transport(GO:0051031) |
0.6 | 1.8 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.6 | 1.8 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.6 | 2.4 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.6 | 1.8 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.6 | 4.2 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.6 | 1.8 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.6 | 1.8 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.6 | 1.7 | GO:0061010 | gall bladder development(GO:0061010) |
0.6 | 1.7 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.6 | 0.6 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.6 | 1.7 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.6 | 1.7 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.6 | 1.7 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.6 | 1.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.6 | 2.2 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.5 | 2.7 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.5 | 2.2 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.5 | 3.8 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.5 | 1.6 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.5 | 2.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.5 | 1.6 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.5 | 1.6 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.5 | 2.1 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.5 | 2.1 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.5 | 1.6 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.5 | 1.1 | GO:0001893 | maternal placenta development(GO:0001893) |
0.5 | 0.5 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
0.5 | 1.5 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.5 | 1.5 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.5 | 0.5 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.5 | 2.0 | GO:0002190 | cap-independent translational initiation(GO:0002190) |
0.5 | 2.0 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.5 | 1.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.5 | 1.5 | GO:0008228 | opsonization(GO:0008228) |
0.5 | 0.5 | GO:0060956 | endocardial cell differentiation(GO:0060956) |
0.5 | 2.4 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.5 | 1.4 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.5 | 1.4 | GO:0019042 | viral latency(GO:0019042) |
0.5 | 2.4 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.5 | 2.4 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.5 | 1.4 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.5 | 0.5 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.5 | 1.9 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.5 | 1.4 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.5 | 1.4 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.5 | 0.5 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.5 | 1.4 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.5 | 2.3 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.5 | 0.9 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.5 | 2.3 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.5 | 1.8 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.5 | 2.3 | GO:0015074 | DNA integration(GO:0015074) |
0.5 | 0.9 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.5 | 2.7 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
0.4 | 3.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.4 | 1.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 1.8 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.4 | 2.7 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.4 | 6.2 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.4 | 1.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.4 | 3.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.4 | 0.9 | GO:0021564 | vagus nerve development(GO:0021564) |
0.4 | 1.3 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.4 | 5.7 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.4 | 1.7 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.4 | 0.9 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.4 | 2.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.4 | 1.3 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.4 | 0.8 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.4 | 2.1 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.4 | 0.4 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.4 | 5.4 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.4 | 0.8 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.4 | 1.2 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.4 | 0.8 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.4 | 4.1 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.4 | 1.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.4 | 1.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.4 | 2.0 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.4 | 1.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.4 | 1.6 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.4 | 1.2 | GO:0061083 | regulation of protein refolding(GO:0061083) |
0.4 | 1.6 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.4 | 2.0 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.4 | 3.6 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
0.4 | 0.8 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.4 | 1.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.4 | 0.8 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.4 | 0.4 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.4 | 2.0 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.4 | 3.1 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.4 | 0.8 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.4 | 0.8 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.4 | 1.2 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.4 | 3.5 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.4 | 2.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 0.4 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.4 | 1.1 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.4 | 1.5 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.4 | 4.6 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.4 | 1.9 | GO:0021612 | facial nerve structural organization(GO:0021612) |
0.4 | 0.4 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.4 | 3.4 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.4 | 0.4 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.4 | 0.7 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.4 | 0.7 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.4 | 0.4 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.4 | 0.7 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.4 | 1.5 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.4 | 1.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.4 | 1.1 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.4 | 0.7 | GO:0070384 | Harderian gland development(GO:0070384) |
0.4 | 1.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.4 | 1.4 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.4 | 1.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.4 | 1.1 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.4 | 5.0 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.4 | 1.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.4 | 1.1 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.4 | 3.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.4 | 0.7 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.4 | 1.4 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.4 | 1.8 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.4 | 1.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.4 | 0.4 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.3 | 1.0 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.3 | 1.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.3 | 1.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 2.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.3 | 0.7 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.3 | 1.7 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.3 | 2.4 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.3 | 1.4 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.3 | 0.7 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.3 | 0.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.3 | 0.3 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.3 | 1.7 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.3 | 0.7 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.3 | 4.0 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.3 | 1.0 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.3 | 0.7 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.3 | 2.3 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.3 | 1.3 | GO:0080009 | mRNA methylation(GO:0080009) |
0.3 | 0.7 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.3 | 3.9 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.3 | 0.3 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.3 | 0.7 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.3 | 1.9 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.3 | 0.6 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
0.3 | 1.3 | GO:0060437 | lung growth(GO:0060437) |
0.3 | 1.9 | GO:0010885 | regulation of cholesterol storage(GO:0010885) |
0.3 | 0.3 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.3 | 1.6 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.3 | 2.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 0.9 | GO:0072126 | positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
0.3 | 1.5 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.3 | 0.3 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.3 | 0.9 | GO:0050955 | thermoception(GO:0050955) |
0.3 | 1.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 1.8 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.3 | 2.7 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.3 | 1.2 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.3 | 0.6 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.3 | 1.5 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.3 | 0.6 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.3 | 1.8 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.3 | 0.9 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.3 | 2.4 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.3 | 0.6 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.3 | 3.3 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.3 | 1.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 3.0 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.3 | 2.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.3 | 1.5 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.3 | 1.8 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.3 | 0.3 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.3 | 1.2 | GO:0043486 | histone exchange(GO:0043486) |
0.3 | 13.1 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.3 | 0.6 | GO:0045472 | response to ether(GO:0045472) |
0.3 | 0.6 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.3 | 1.4 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.3 | 2.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.3 | 0.9 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.3 | 0.9 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.3 | 1.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.3 | 0.6 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.3 | 0.9 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.3 | 0.3 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.3 | 1.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.3 | 1.4 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.3 | 0.3 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.3 | 0.8 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.3 | 1.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.3 | 2.2 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.3 | 1.1 | GO:0001842 | neural fold formation(GO:0001842) |
0.3 | 0.3 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
0.3 | 1.4 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.3 | 0.3 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.3 | 0.8 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.3 | 0.3 | GO:0090314 | positive regulation of protein targeting to membrane(GO:0090314) |
0.3 | 0.8 | GO:0051665 | membrane raft localization(GO:0051665) |
0.3 | 0.5 | GO:1903416 | response to glycoside(GO:1903416) |
0.3 | 1.6 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.3 | 1.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.3 | 2.2 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.3 | 0.8 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.3 | 0.5 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.3 | 1.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.3 | 0.8 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.3 | 0.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.3 | 1.3 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.3 | 1.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.3 | 0.5 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.3 | 0.5 | GO:0009414 | response to water deprivation(GO:0009414) |
0.3 | 0.3 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.3 | 0.3 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.3 | 1.6 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.3 | 0.5 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.3 | 2.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.3 | 2.6 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.3 | 0.5 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.3 | 1.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.3 | 0.3 | GO:0002159 | desmosome assembly(GO:0002159) |
0.3 | 1.3 | GO:0033504 | floor plate development(GO:0033504) |
0.3 | 1.5 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.3 | 0.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.3 | 1.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.3 | 0.8 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.3 | 0.5 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.3 | 0.3 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.3 | 0.8 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.3 | 0.8 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.3 | 0.8 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.3 | 0.5 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.3 | 0.8 | GO:0030952 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.3 | 1.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.3 | 4.5 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.3 | 2.0 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.3 | 0.5 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.3 | 1.0 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.3 | 0.3 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
0.3 | 1.8 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.2 | 0.5 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.2 | 0.7 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.2 | 0.7 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 1.5 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.2 | 1.0 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 2.7 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.2 | 1.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 1.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 0.7 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 4.9 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 0.5 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.2 | 0.2 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.2 | 1.0 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.2 | 0.7 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.2 | 1.7 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.2 | 1.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 0.2 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.2 | 0.2 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.2 | 1.4 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 0.7 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.2 | 0.5 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
0.2 | 0.5 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.2 | 0.7 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.2 | 0.9 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.2 | 1.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 0.7 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 0.7 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.2 | 0.2 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.2 | 1.4 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 0.9 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.2 | 3.0 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 0.5 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.2 | 1.4 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.2 | 0.7 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 3.0 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 0.9 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 1.8 | GO:0001660 | fever generation(GO:0001660) |
0.2 | 0.5 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.2 | 1.1 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.2 | 0.2 | GO:0000965 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) mitochondrial RNA 3'-end processing(GO:0000965) |
0.2 | 0.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 0.2 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
0.2 | 0.5 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.2 | 0.2 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.2 | 0.2 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 0.9 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 0.9 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.2 | 2.7 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 0.7 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 3.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.2 | 1.6 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.2 | 0.9 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.2 | 0.7 | GO:0010042 | response to manganese ion(GO:0010042) |
0.2 | 0.7 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 0.7 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.2 | 3.9 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.2 | 0.9 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.7 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.2 | 0.4 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.2 | 0.7 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 1.5 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.2 | 2.6 | GO:0046697 | decidualization(GO:0046697) |
0.2 | 0.4 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.2 | 0.4 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.2 | 1.3 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 0.4 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.2 | 1.9 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 1.1 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.2 | 2.1 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.2 | 0.4 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.2 | 0.6 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.2 | 1.5 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
0.2 | 1.5 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 0.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 1.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.2 | 0.2 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.2 | 1.0 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.2 | 0.6 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.2 | 1.0 | GO:0021764 | amygdala development(GO:0021764) |
0.2 | 1.0 | GO:2000109 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.2 | 1.5 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.2 | 1.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 0.2 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.2 | 1.0 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 1.7 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.2 | 1.0 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.2 | 0.4 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.2 | 0.2 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.2 | 0.2 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.2 | 0.8 | GO:1901881 | positive regulation of microtubule depolymerization(GO:0031117) positive regulation of protein depolymerization(GO:1901881) |
0.2 | 0.6 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.2 | 0.4 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.2 | 0.2 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.2 | 0.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 0.2 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.2 | 2.4 | GO:0001945 | lymph vessel development(GO:0001945) |
0.2 | 1.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 1.8 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.2 | 1.0 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.2 | 0.2 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.2 | 0.6 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.2 | 0.4 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.2 | 0.6 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) |
0.2 | 2.0 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.2 | 0.8 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.2 | 2.4 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.2 | 1.0 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.2 | 0.8 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.2 | 1.0 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.2 | 0.2 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.2 | 0.8 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.2 | 1.0 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.2 | 0.2 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.2 | 0.2 | GO:0007418 | ventral midline development(GO:0007418) |
0.2 | 0.6 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.2 | 0.4 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 0.4 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.2 | 0.4 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.2 | 0.6 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.2 | 0.8 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 0.4 | GO:0035425 | autocrine signaling(GO:0035425) |
0.2 | 2.4 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.2 | 0.2 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.2 | 0.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 2.7 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.4 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.2 | 0.6 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.2 | 0.8 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.2 | 0.6 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.2 | 1.0 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 1.0 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 0.4 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.2 | 0.4 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.2 | 1.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 0.6 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.2 | 0.2 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.2 | 1.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 0.2 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.2 | 1.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 0.4 | GO:0051256 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
0.2 | 0.2 | GO:0021888 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.2 | 0.2 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.2 | 0.6 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 2.8 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.2 | 0.2 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
0.2 | 0.4 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.2 | 1.7 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.2 | 2.2 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 0.7 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.2 | 1.3 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.2 | 1.1 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.2 | 0.6 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.2 | 0.5 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.2 | 0.4 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.2 | 0.5 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 2.6 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.2 | 0.4 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.2 | 0.9 | GO:0044804 | nucleophagy(GO:0044804) |
0.2 | 0.7 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.2 | 0.4 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.2 | 1.3 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 0.5 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 0.7 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.2 | 0.2 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.2 | 0.4 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.2 | 0.9 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.2 | 1.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 0.7 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.2 | 0.4 | GO:0043243 | positive regulation of protein complex disassembly(GO:0043243) |
0.2 | 1.6 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.2 | 1.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.2 | 0.9 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 2.5 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 1.2 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 1.6 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.2 | 0.4 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.2 | 0.4 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.2 | 1.6 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 0.5 | GO:0034214 | protein hexamerization(GO:0034214) |
0.2 | 0.9 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.2 | 0.5 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.9 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 0.5 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 0.5 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.2 | 0.3 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 | 0.3 | GO:0019081 | viral translation(GO:0019081) |
0.2 | 1.2 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.2 | 0.5 | GO:0003283 | atrial septum development(GO:0003283) |
0.2 | 0.2 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.2 | 0.2 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.2 | 1.7 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.2 | 0.7 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.2 | 1.9 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.2 | 0.3 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 0.5 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.2 | 1.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 0.9 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.2 | 0.5 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 0.2 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.2 | 0.8 | GO:0043574 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.2 | 0.2 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.2 | 0.3 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 0.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 1.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 1.0 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.2 | 0.3 | GO:0002432 | granuloma formation(GO:0002432) |
0.2 | 0.3 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.2 | 0.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 0.7 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.2 | 0.2 | GO:0060379 | cardiac muscle cell myoblast differentiation(GO:0060379) |
0.2 | 0.2 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.2 | 0.8 | GO:1904970 | brush border assembly(GO:1904970) |
0.2 | 0.7 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 0.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.2 | 0.5 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 1.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.8 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 0.3 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.2 | 1.5 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.2 | 0.2 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.2 | 0.3 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.2 | 1.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.5 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 1.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 0.2 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.2 | 1.8 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.2 | 0.3 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.2 | 0.6 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 0.5 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.2 | 1.9 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.2 | 0.2 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.2 | 0.2 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.2 | 0.5 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 0.5 | GO:0046135 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.2 | 0.8 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 0.5 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.2 | 1.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.5 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.2 | 0.2 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.2 | 0.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 3.8 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.2 | 0.9 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.2 | 0.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.2 | 0.5 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 0.3 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.2 | 2.8 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.2 | 0.5 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.2 | 0.6 | GO:0031033 | myosin filament organization(GO:0031033) |
0.2 | 0.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.2 | 0.3 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 0.6 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.2 | 0.3 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.2 | 0.8 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.2 | 0.3 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.2 | 0.6 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 0.6 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 0.2 | GO:2000779 | regulation of double-strand break repair(GO:2000779) |
0.2 | 1.5 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 0.8 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 4.3 | GO:0006414 | translational elongation(GO:0006414) |
0.2 | 0.5 | GO:0048478 | replication fork protection(GO:0048478) |
0.2 | 0.9 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.2 | 0.9 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 0.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 0.3 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.2 | 0.8 | GO:0006266 | DNA ligation(GO:0006266) |
0.2 | 0.5 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.2 | 0.5 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 0.9 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.1 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.1 | 0.7 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.3 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 0.4 | GO:0006188 | IMP biosynthetic process(GO:0006188) purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.1 | 0.9 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 5.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.6 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.4 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.7 | GO:0031295 | T cell costimulation(GO:0031295) |
0.1 | 0.3 | GO:0090382 | phagosome maturation(GO:0090382) |
0.1 | 0.6 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.1 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 3.9 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 1.0 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.1 | 1.0 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.3 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.1 | 0.4 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.1 | 0.6 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 0.7 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.3 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.1 | 0.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 4.2 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.3 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.1 | 0.4 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 0.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 1.1 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.1 | 0.3 | GO:0001840 | neural plate development(GO:0001840) |
0.1 | 0.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.6 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.1 | 0.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 1.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 0.4 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 1.8 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.4 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.3 | GO:0050904 | diapedesis(GO:0050904) |
0.1 | 1.2 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.1 | 0.7 | GO:0015879 | carnitine transport(GO:0015879) |
0.1 | 0.3 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 0.7 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.1 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.1 | 0.5 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.4 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.4 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 0.8 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.1 | 1.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.5 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 0.1 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.1 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.1 | 0.1 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.1 | 0.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.5 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.5 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 0.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 1.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.8 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 0.5 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.1 | 0.8 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 0.3 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.5 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.1 | GO:1902566 | regulation of eosinophil activation(GO:1902566) |
0.1 | 0.7 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.5 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 0.9 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.3 | GO:0051383 | kinetochore organization(GO:0051383) |
0.1 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.4 | GO:0035733 | hepatic stellate cell activation(GO:0035733) |
0.1 | 0.6 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.1 | 0.1 | GO:0060534 | trachea cartilage development(GO:0060534) |
0.1 | 0.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.4 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.1 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.1 | 0.3 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) positive regulation of maintenance of sister chromatid cohesion(GO:0034093) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.1 | 1.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 1.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 2.4 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.3 | GO:0035928 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
0.1 | 0.3 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 0.5 | GO:0007619 | courtship behavior(GO:0007619) |
0.1 | 0.4 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 0.5 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 2.3 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.3 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 0.2 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 1.0 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.6 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.5 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.5 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 0.1 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.1 | 0.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.9 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.7 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 0.1 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.1 | 0.1 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.1 | 0.4 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.4 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.6 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 1.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.1 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.1 | 0.2 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.1 | 0.8 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.1 | 0.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.5 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.7 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.1 | 0.1 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.1 | 0.4 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 0.2 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 0.1 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.1 | 0.1 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.1 | 0.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 3.2 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 1.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.3 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.1 | 0.3 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.1 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 1.1 | GO:0035588 | G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 0.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.1 | 1.0 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.1 | 0.2 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.1 | 0.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.9 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.1 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.1 | 1.1 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.8 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.1 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 1.0 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.1 | 1.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.1 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.1 | 0.6 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.2 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 0.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.1 | 0.2 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.1 | 0.2 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.6 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.6 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.1 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.1 | 0.1 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.1 | 0.3 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.1 | 0.7 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.1 | 0.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.7 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 0.9 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.1 | 0.1 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.1 | 2.3 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.5 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 0.2 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 0.1 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.8 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.2 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.1 | 0.7 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 1.2 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 1.3 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 0.2 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.3 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.1 | 0.4 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.1 | 0.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 2.3 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.1 | 0.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.1 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.1 | 0.8 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.1 | 0.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.8 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.1 | 0.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.1 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.1 | 0.6 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 0.2 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.1 | 0.2 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 2.3 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.1 | 0.1 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.1 | 0.4 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.1 | GO:0036166 | phenotypic switching(GO:0036166) |
0.1 | 0.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.3 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
0.1 | 0.9 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 1.2 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.1 | 0.4 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.5 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.1 | 0.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.3 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.1 | 0.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.3 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.1 | 0.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.8 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 0.2 | GO:0070836 | caveola assembly(GO:0070836) |
0.1 | 0.1 | GO:1904748 | regulation of apoptotic process involved in development(GO:1904748) |
0.1 | 0.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.2 | GO:0060026 | convergent extension(GO:0060026) |
0.1 | 1.0 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 2.5 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 1.0 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 0.4 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.8 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.2 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.1 | 0.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.6 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 0.4 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 0.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.1 | 1.2 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.3 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 0.2 | GO:0097468 | hydrogen peroxide-mediated programmed cell death(GO:0010421) programmed cell death in response to reactive oxygen species(GO:0097468) regulation of hydrogen peroxide-mediated programmed cell death(GO:1901298) |
0.1 | 0.4 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.1 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.1 | 0.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.4 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.1 | GO:0010878 | cholesterol storage(GO:0010878) |
0.1 | 0.4 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.1 | 0.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.1 | 0.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.3 | GO:0098751 | osteoclast development(GO:0036035) bone cell development(GO:0098751) |
0.1 | 0.5 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.1 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.1 | 0.5 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.4 | GO:1900225 | regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
0.1 | 0.4 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.1 | 0.4 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.1 | 0.5 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.2 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.1 | GO:2000705 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
0.1 | 0.4 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.1 | 0.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.6 | GO:0045779 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
0.1 | 1.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.4 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 0.1 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.1 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.1 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.1 | 0.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.1 | 0.4 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 0.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.1 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.3 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.1 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.1 | 0.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 2.2 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.1 | 0.8 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.2 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.1 | 0.2 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.1 | 0.4 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 3.5 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 1.0 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.2 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.1 | 0.5 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 0.2 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.4 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.1 | 0.3 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.1 | 0.2 | GO:0060571 | morphogenesis of an epithelial fold(GO:0060571) |
0.1 | 0.5 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.1 | GO:0021546 | rhombomere development(GO:0021546) |
0.1 | 0.3 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.3 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.3 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.2 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 0.4 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.1 | GO:0035088 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.1 | 0.2 | GO:0035483 | gastric emptying(GO:0035483) |
0.1 | 0.3 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.2 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.1 | 0.2 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.1 | 0.1 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
0.1 | 0.3 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 1.2 | GO:0060384 | innervation(GO:0060384) |
0.1 | 0.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.2 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.1 | 1.8 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 2.9 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.1 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.1 | 0.6 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.3 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.5 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.2 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.2 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.7 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 0.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 0.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.2 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.1 | 2.5 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
0.1 | 0.1 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.1 | 0.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 1.6 | GO:0007492 | endoderm development(GO:0007492) |
0.1 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.4 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.1 | 0.9 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.2 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.2 | GO:0051647 | nucleus localization(GO:0051647) |
0.1 | 0.9 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.3 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.1 | 1.4 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.3 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 0.6 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.8 | GO:1901739 | regulation of myoblast fusion(GO:1901739) |
0.1 | 0.3 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 0.3 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.4 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.1 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.1 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.1 | 0.2 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.1 | 0.3 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.3 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.1 | 0.1 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.1 | 0.4 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.2 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 0.2 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.1 | 0.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 1.5 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.4 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 1.0 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.2 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 0.1 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.1 | 0.4 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 0.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.1 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 1.1 | GO:0003016 | respiratory system process(GO:0003016) |
0.1 | 0.3 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.2 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.1 | GO:0001798 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.1 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.1 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.1 | 0.8 | GO:0030539 | male genitalia development(GO:0030539) |
0.1 | 0.1 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.2 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.1 | 0.6 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.1 | 0.7 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 0.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 1.7 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.1 | 0.2 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.3 | GO:1990090 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
0.1 | 0.5 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.5 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 0.1 | GO:0043368 | positive T cell selection(GO:0043368) |
0.1 | 0.9 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.1 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.1 | 0.2 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.5 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.3 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.1 | 0.2 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.1 | 0.5 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.6 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.5 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.3 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.1 | GO:0045072 | regulation of interferon-gamma biosynthetic process(GO:0045072) |
0.1 | 0.9 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.5 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 1.0 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.6 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 0.2 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.1 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 0.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 0.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.3 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 1.5 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 | 0.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.1 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.6 | GO:0070633 | transepithelial transport(GO:0070633) |
0.1 | 0.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.2 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 2.0 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.1 | 0.4 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.1 | 0.1 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.1 | 0.4 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.1 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 0.6 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.1 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 0.4 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 0.1 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.1 | GO:0021593 | rhombomere 3 development(GO:0021569) rhombomere morphogenesis(GO:0021593) |
0.1 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.8 | GO:1903825 | organic acid transmembrane transport(GO:1903825) carboxylic acid transmembrane transport(GO:1905039) |
0.1 | 0.2 | GO:0071554 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
0.1 | 0.3 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.1 | 0.1 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
0.1 | 0.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.5 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.1 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 1.3 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.1 | 0.1 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.1 | 0.1 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.1 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.1 | 0.3 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.1 | GO:1901031 | regulation of response to reactive oxygen species(GO:1901031) |
0.1 | 0.4 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.1 | GO:0072202 | cell differentiation involved in metanephros development(GO:0072202) |
0.1 | 0.1 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.1 | 0.8 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 1.5 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.2 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.1 | 0.5 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 0.2 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.1 | GO:0061525 | hindgut development(GO:0061525) |
0.1 | 0.3 | GO:0048854 | brain morphogenesis(GO:0048854) |
0.1 | 1.3 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.9 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.1 | 0.1 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.1 | 0.9 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 | 0.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.1 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.1 | 0.2 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.1 | 0.1 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.1 | 0.9 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 0.2 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.2 | GO:0003179 | heart valve morphogenesis(GO:0003179) |
0.1 | 0.1 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.1 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.8 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.1 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.5 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.1 | GO:0097421 | liver regeneration(GO:0097421) |
0.1 | 0.1 | GO:0050923 | axon midline choice point recognition(GO:0016199) regulation of negative chemotaxis(GO:0050923) |
0.1 | 0.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.2 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 0.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.6 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.1 | 0.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.5 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.1 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.1 | 0.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.1 | GO:0051295 | polar body extrusion after meiotic divisions(GO:0040038) establishment of meiotic spindle localization(GO:0051295) formin-nucleated actin cable assembly(GO:0070649) |
0.1 | 0.1 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 0.1 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.1 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.1 | GO:0002724 | regulation of T cell cytokine production(GO:0002724) positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 0.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.3 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 0.3 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.1 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.1 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.0 | 0.3 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.0 | 0.0 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.1 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.4 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 2.2 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.1 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.0 | 0.1 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.2 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.0 | 0.1 | GO:1904874 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.0 | 0.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.1 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.0 | 0.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.0 | 0.1 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.0 | 1.3 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 0.3 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.1 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.2 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.6 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.2 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.0 | 0.3 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 0.1 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.0 | 0.1 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.0 | 0.2 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.2 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.0 | 0.0 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.0 | 0.0 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.0 | 0.9 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.0 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.0 | 0.2 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.0 | 0.3 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.0 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.0 | 0.2 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.3 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.0 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.0 | 0.1 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.0 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 1.0 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.0 | 0.3 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.1 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
0.0 | 0.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.0 | 0.7 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.0 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.0 | 0.0 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.0 | 0.3 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.0 | 0.2 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.0 | 0.0 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.0 | 1.0 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.0 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.0 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.0 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.0 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.0 | 1.1 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.0 | 0.1 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.0 | GO:1900746 | vascular endothelial growth factor signaling pathway(GO:0038084) regulation of vascular endothelial growth factor signaling pathway(GO:1900746) regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.0 | 0.4 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.1 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.0 | 0.3 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.0 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.0 | 0.0 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.0 | 0.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.2 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.0 | 0.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.3 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.7 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.0 | 1.0 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.2 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.0 | 0.7 | GO:0003281 | ventricular septum development(GO:0003281) |
0.0 | 0.1 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.0 | 0.1 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.0 | 0.0 | GO:0042148 | strand invasion(GO:0042148) |
0.0 | 0.2 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.3 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.4 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.4 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.1 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.0 | 0.0 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.0 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.0 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.0 | 0.1 | GO:0014841 | skeletal muscle satellite cell proliferation(GO:0014841) |
0.0 | 0.0 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.0 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.1 | GO:0032095 | regulation of response to food(GO:0032095) |
0.0 | 0.1 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.0 | 0.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.4 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.0 | 0.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.0 | 0.4 | GO:0060074 | synapse maturation(GO:0060074) |
0.0 | 0.4 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 | 0.0 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.0 | 0.0 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.0 | 0.0 | GO:0022605 | oogenesis stage(GO:0022605) |
0.0 | 0.2 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.1 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.1 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.0 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.0 | 0.2 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.1 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.0 | 0.3 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.0 | 0.5 | GO:0045143 | homologous chromosome segregation(GO:0045143) |
0.0 | 0.1 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.0 | 0.0 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.0 | 0.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.0 | 0.0 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
0.0 | 0.1 | GO:0002467 | germinal center formation(GO:0002467) |
0.0 | 0.1 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.0 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.0 | 0.0 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.0 | 0.3 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 0.0 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.0 | 0.1 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.1 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.0 | 0.0 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.0 | 0.0 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.0 | 0.6 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.2 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.0 | 0.0 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.0 | 0.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.0 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.1 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.0 | 0.1 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.0 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.0 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.2 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.0 | 0.0 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.2 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.2 | GO:0061097 | regulation of protein tyrosine kinase activity(GO:0061097) |
0.0 | 0.9 | GO:0007338 | single fertilization(GO:0007338) |
0.0 | 0.0 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.0 | 0.5 | GO:0032606 | type I interferon production(GO:0032606) |
0.0 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.0 | 0.1 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.0 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.0 | 0.0 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.0 | 0.1 | GO:0032925 | regulation of activin receptor signaling pathway(GO:0032925) |
0.0 | 0.1 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.0 | 0.1 | GO:0007625 | grooming behavior(GO:0007625) |
0.0 | 1.4 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 0.5 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.2 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.1 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.0 | 0.2 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 0.3 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.0 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.1 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.0 | 0.3 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.0 | 0.3 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.0 | 0.2 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.0 | 0.2 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.0 | GO:0060290 | transdifferentiation(GO:0060290) |
0.0 | 0.1 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.0 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.0 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.0 | 0.0 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.0 | 0.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.0 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.0 | 0.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.0 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.0 | 0.0 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.0 | 0.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.2 | GO:0060393 | regulation of pathway-restricted SMAD protein phosphorylation(GO:0060393) |
0.0 | 0.1 | GO:0043482 | endosome to melanosome transport(GO:0035646) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.0 | 0.1 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.2 | GO:0070166 | enamel mineralization(GO:0070166) |
0.0 | 0.1 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.0 | 0.4 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.0 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.0 | 0.1 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.0 | 0.1 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.4 | GO:0030816 | positive regulation of cAMP metabolic process(GO:0030816) |
0.0 | 0.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.0 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.0 | 0.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.1 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.0 | GO:0061055 | myotome development(GO:0061055) |
0.0 | 0.1 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.1 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.0 | 0.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.0 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.0 | 0.1 | GO:0045823 | positive regulation of heart contraction(GO:0045823) |
0.0 | 0.0 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
0.0 | 0.0 | GO:0098754 | detoxification(GO:0098754) |
0.0 | 0.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.0 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.0 | 0.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.3 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.2 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 0.2 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.0 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.0 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.0 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.1 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.0 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 1.1 | GO:0050658 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) |
0.0 | 0.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.0 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.0 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.0 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.0 | 0.1 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 0.5 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.0 | 0.2 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.1 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.1 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 0.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.5 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.9 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.0 | 0.0 | GO:0042220 | response to cocaine(GO:0042220) |
0.0 | 0.1 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.0 | 0.0 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.0 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.0 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.0 | 0.0 | GO:0061515 | myeloid cell development(GO:0061515) |
0.0 | 0.0 | GO:0006837 | serotonin transport(GO:0006837) |
0.0 | 0.0 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.0 | 0.8 | GO:0030509 | BMP signaling pathway(GO:0030509) |
0.0 | 0.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.0 | GO:0048846 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.0 | 0.0 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.0 | 0.1 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.0 | 0.0 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.0 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.0 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.0 | 0.3 | GO:0048144 | fibroblast proliferation(GO:0048144) |
0.0 | 0.0 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.1 | GO:0042698 | ovulation cycle(GO:0042698) |
0.0 | 0.1 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.0 | 0.1 | GO:0031100 | organ regeneration(GO:0031100) |
0.0 | 0.1 | GO:1901072 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.6 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.1 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.0 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.0 | GO:0099558 | motor learning(GO:0061743) maintenance of synapse structure(GO:0099558) |
0.0 | 0.0 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.0 | 0.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.0 | GO:0060142 | regulation of syncytium formation by plasma membrane fusion(GO:0060142) |
0.0 | 0.0 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.0 | 0.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.1 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) syncytium formation(GO:0006949) |
0.0 | 0.0 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.1 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.0 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.0 | 0.0 | GO:0032372 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
0.0 | 0.0 | GO:0042069 | regulation of catecholamine metabolic process(GO:0042069) |
0.0 | 0.0 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.0 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) |
0.0 | 0.0 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.0 | 0.1 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 0.0 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.0 | 0.0 | GO:0043584 | nose development(GO:0043584) |
0.0 | 0.1 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.0 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.0 | 0.0 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.0 | 0.1 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.0 | 0.0 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.0 | 0.0 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 | 0.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.0 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.0 | GO:0035886 | vascular smooth muscle cell differentiation(GO:0035886) |
0.0 | 0.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.2 | GO:0036503 | ERAD pathway(GO:0036503) |
0.0 | 0.0 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.0 | 0.0 | GO:0098810 | neurotransmitter reuptake(GO:0098810) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.5 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.8 | 2.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.8 | 2.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.8 | 2.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.7 | 1.4 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.7 | 2.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.7 | 2.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.6 | 1.3 | GO:0000243 | commitment complex(GO:0000243) |
0.6 | 4.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.6 | 1.8 | GO:0031523 | Myb complex(GO:0031523) |
0.6 | 1.8 | GO:0036396 | MIS complex(GO:0036396) |
0.6 | 3.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.6 | 2.8 | GO:0070695 | FHF complex(GO:0070695) |
0.6 | 1.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.5 | 1.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.5 | 2.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.5 | 2.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.5 | 4.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.5 | 2.5 | GO:0061617 | MICOS complex(GO:0061617) |
0.5 | 2.5 | GO:0097255 | R2TP complex(GO:0097255) |
0.5 | 1.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.5 | 1.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.4 | 2.7 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.4 | 0.4 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.4 | 3.1 | GO:0005688 | U6 snRNP(GO:0005688) |
0.4 | 1.3 | GO:0031417 | NatC complex(GO:0031417) |
0.4 | 4.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.4 | 1.6 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.4 | 1.2 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.4 | 4.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.4 | 1.2 | GO:1990462 | omegasome(GO:1990462) |
0.4 | 2.7 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.4 | 1.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.4 | 2.7 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.4 | 3.0 | GO:0034464 | BBSome(GO:0034464) |
0.4 | 0.4 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.4 | 3.0 | GO:0070652 | HAUS complex(GO:0070652) |
0.4 | 1.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.4 | 1.5 | GO:0072487 | MSL complex(GO:0072487) |
0.4 | 1.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.4 | 2.2 | GO:0016589 | NURF complex(GO:0016589) |
0.4 | 2.9 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.4 | 5.0 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.4 | 1.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.4 | 1.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.4 | 0.7 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 1.0 | GO:0005745 | m-AAA complex(GO:0005745) |
0.3 | 1.0 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.3 | 2.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 1.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 0.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 1.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 1.7 | GO:0005683 | U7 snRNP(GO:0005683) |
0.3 | 1.0 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 1.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 1.0 | GO:0005955 | calcineurin complex(GO:0005955) |
0.3 | 1.9 | GO:0097342 | ripoptosome(GO:0097342) |
0.3 | 1.0 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.3 | 1.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 1.9 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.3 | 1.6 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.3 | 8.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 0.9 | GO:0097427 | microtubule bundle(GO:0097427) |
0.3 | 5.5 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.3 | 0.9 | GO:1990393 | 3M complex(GO:1990393) |
0.3 | 4.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.3 | 0.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.3 | 3.2 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.3 | 1.2 | GO:1990745 | EARP complex(GO:1990745) |
0.3 | 1.2 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.3 | 1.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.3 | 0.3 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.3 | 0.8 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.3 | 1.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.3 | 2.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 2.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.3 | 1.6 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 0.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 0.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 1.6 | GO:0005818 | aster(GO:0005818) |
0.3 | 0.8 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.3 | 0.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.3 | 0.8 | GO:0043511 | inhibin complex(GO:0043511) |
0.3 | 1.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.3 | 1.5 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.3 | 0.3 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 3.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.2 | 1.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 2.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 2.2 | GO:0030686 | 90S preribosome(GO:0030686) |
0.2 | 2.0 | GO:0032797 | SMN complex(GO:0032797) |
0.2 | 5.9 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 0.7 | GO:0001652 | granular component(GO:0001652) |
0.2 | 0.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 1.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 2.2 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 1.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 0.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 1.6 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 1.6 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 3.2 | GO:0071565 | nBAF complex(GO:0071565) |
0.2 | 1.4 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 1.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.2 | 5.3 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 0.7 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.2 | 0.4 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.2 | 4.2 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 0.2 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.2 | 0.7 | GO:0044308 | axonal spine(GO:0044308) |
0.2 | 0.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 0.4 | GO:0097441 | basilar dendrite(GO:0097441) |
0.2 | 0.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.2 | 0.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 0.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.6 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.2 | 1.1 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 1.7 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.2 | 0.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 1.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 2.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.2 | 1.0 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 0.6 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.2 | 1.0 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 0.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 4.2 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 0.8 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 0.6 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 1.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 1.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 1.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 0.2 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 1.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 1.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 0.2 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 0.6 | GO:0042825 | TAP complex(GO:0042825) |
0.2 | 1.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 1.9 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.2 | 1.9 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.2 | 1.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.2 | 2.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 4.9 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 4.1 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 1.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 0.7 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.2 | 0.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 1.5 | GO:0016580 | Sin3 complex(GO:0016580) |
0.2 | 1.4 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.2 | 2.0 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 0.4 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.2 | 1.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 0.7 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 1.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 0.9 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 0.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 1.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 1.7 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 1.7 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 0.9 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 5.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 0.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 0.7 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 0.8 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 3.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 1.3 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 0.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 0.6 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 1.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 0.5 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.2 | 0.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 6.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 1.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 0.9 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 0.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.5 | GO:0070069 | cytochrome complex(GO:0070069) |
0.2 | 1.4 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.2 | 0.2 | GO:0000791 | euchromatin(GO:0000791) |
0.2 | 0.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 0.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 0.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 0.2 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 1.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 4.0 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.1 | 1.0 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 1.0 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.4 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 1.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 2.9 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.3 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 2.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 1.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 1.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.9 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 0.8 | GO:0012506 | vesicle membrane(GO:0012506) |
0.1 | 0.4 | GO:0031931 | TORC1 complex(GO:0031931) TOR complex(GO:0038201) |
0.1 | 0.9 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.5 | GO:0098576 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.1 | 0.3 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 5.8 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.8 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.4 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 1.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 1.4 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 0.4 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.2 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 0.9 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 1.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 1.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.3 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.1 | 0.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.9 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 1.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 0.9 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 1.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 2.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.8 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.5 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.8 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.1 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 1.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 4.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 1.5 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.5 | GO:0000801 | central element(GO:0000801) |
0.1 | 1.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.5 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.2 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.1 | 0.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 0.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.4 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.5 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.2 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 0.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.4 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 8.9 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.7 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 6.4 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 4.2 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.6 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 0.6 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 5.0 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 2.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.3 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.3 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.8 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 1.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 5.1 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.1 | 0.1 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.1 | 0.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.7 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.2 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 0.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.4 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 6.4 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.9 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 1.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.3 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.3 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.1 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.1 | 0.1 | GO:1990696 | USH2 complex(GO:1990696) |
0.1 | 2.8 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.1 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 0.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 1.1 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.8 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 1.3 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 3.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.8 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.1 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 0.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.9 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.3 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.3 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.5 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.4 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.7 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.8 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 1.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 1.1 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 1.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.9 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 4.6 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 2.9 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.2 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 0.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 1.1 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.4 | GO:0030118 | clathrin coat(GO:0030118) |
0.1 | 0.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 2.3 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 0.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 1.2 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 0.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.7 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.9 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 1.4 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.5 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 1.6 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.1 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.0 | 0.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.5 | GO:0031256 | leading edge membrane(GO:0031256) |
0.0 | 0.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.2 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.2 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 4.4 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 1.4 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.2 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 7.2 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.8 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.2 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.0 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 0.9 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.9 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.7 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.0 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 0.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.6 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.4 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 1.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 2.9 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 2.7 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.3 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.0 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 0.2 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.0 | 2.0 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 1.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.1 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.2 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 3.1 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 0.3 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.0 | 0.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.1 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.0 | 3.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.7 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.1 | GO:0016528 | sarcoplasm(GO:0016528) |
0.0 | 0.2 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 1.6 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.4 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 0.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 0.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 1.6 | GO:0030141 | secretory granule(GO:0030141) |
0.0 | 0.3 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.1 | GO:0098800 | inner mitochondrial membrane protein complex(GO:0098800) |
0.0 | 0.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.0 | GO:0097433 | dense body(GO:0097433) |
0.0 | 0.0 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 0.1 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 0.6 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.1 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.3 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 3.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.3 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.0 | 0.1 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
0.0 | 0.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 5.3 | GO:0031410 | cytoplasmic vesicle(GO:0031410) |
0.0 | 1.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.0 | GO:0030684 | preribosome(GO:0030684) |
0.0 | 0.0 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.0 | 0.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.8 | GO:0072372 | primary cilium(GO:0072372) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 1.3 | GO:0030487 | inositol-4,5-bisphosphate 5-phosphatase activity(GO:0030487) |
1.3 | 1.3 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
1.1 | 3.4 | GO:0001032 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
1.0 | 3.1 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.0 | 3.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.9 | 0.9 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.9 | 2.7 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.9 | 2.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.8 | 4.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.8 | 0.8 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.8 | 2.4 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.8 | 2.3 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.8 | 0.8 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.8 | 4.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.7 | 2.2 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.7 | 6.4 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.7 | 2.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.7 | 0.7 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.7 | 2.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.7 | 4.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.6 | 1.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.6 | 1.9 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.6 | 4.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.6 | 2.4 | GO:0036033 | mediator complex binding(GO:0036033) |
0.6 | 3.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.6 | 2.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.6 | 1.7 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.6 | 1.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.6 | 1.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.6 | 1.7 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.6 | 1.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.5 | 2.7 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.5 | 1.6 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.5 | 2.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.5 | 6.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.5 | 2.1 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.5 | 4.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 2.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.5 | 0.5 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.5 | 1.4 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.5 | 2.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.5 | 1.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.5 | 2.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.5 | 1.8 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.5 | 1.4 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.5 | 1.4 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.5 | 1.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.4 | 2.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 0.9 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.4 | 2.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.4 | 0.4 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.4 | 5.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.4 | 0.8 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.4 | 1.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.4 | 1.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.4 | 2.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.4 | 1.2 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.4 | 0.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.4 | 0.4 | GO:0030352 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.4 | 1.1 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.4 | 1.1 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.4 | 0.4 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.4 | 2.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.4 | 1.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 0.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.4 | 2.2 | GO:0035473 | lipase binding(GO:0035473) |
0.4 | 1.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.4 | 1.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.4 | 1.8 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.4 | 2.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.3 | 0.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.3 | 1.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 0.7 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.3 | 1.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.3 | 3.4 | GO:0015266 | protein channel activity(GO:0015266) |
0.3 | 2.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 2.0 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.3 | 1.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.3 | 1.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.3 | 2.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 0.3 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.3 | 2.9 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.3 | 6.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 2.9 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.3 | 0.6 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.3 | 3.5 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.3 | 1.6 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.3 | 1.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.3 | 2.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 1.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 0.6 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 2.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.3 | 2.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.3 | 3.1 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.3 | 0.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.3 | 0.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 0.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.3 | 2.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 0.9 | GO:0030519 | snoRNP binding(GO:0030519) |
0.3 | 1.5 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.3 | 1.5 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.3 | 0.9 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.3 | 0.6 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.3 | 1.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.3 | 0.8 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 1.7 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.3 | 0.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.3 | 0.3 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.3 | 0.8 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.3 | 1.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.3 | 1.9 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 1.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 3.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 1.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.3 | 0.5 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.3 | 0.5 | GO:0043398 | HLH domain binding(GO:0043398) |
0.3 | 2.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.3 | 2.9 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.3 | 0.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 1.0 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.3 | 9.4 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.3 | 0.3 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.3 | 1.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 0.8 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.3 | 4.9 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 0.8 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.3 | 1.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.3 | 1.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 1.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 0.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 0.7 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.2 | 0.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.2 | 2.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 1.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 3.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 2.9 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 1.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.2 | 2.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 1.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 0.5 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.2 | 0.9 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 0.9 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 0.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 0.5 | GO:0070061 | fructose binding(GO:0070061) |
0.2 | 0.5 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 2.5 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.2 | 0.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 1.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 0.7 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.2 | 0.4 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.2 | 0.4 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.2 | 1.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 0.7 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 0.7 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 0.7 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 0.9 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.2 | 2.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 0.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 2.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 1.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.2 | 2.4 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 0.9 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 1.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.2 | 0.8 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 0.8 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 0.6 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 4.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 0.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 0.2 | GO:0008169 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.2 | 1.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.2 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 1.6 | GO:0017065 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.2 | 0.8 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 2.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 1.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 0.6 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 1.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 1.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 3.0 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.2 | 0.6 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 0.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 1.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 0.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 1.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 1.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 0.8 | GO:0043559 | insulin binding(GO:0043559) |
0.2 | 0.6 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 0.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.2 | 0.6 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.2 | 0.4 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.2 | 0.4 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 1.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 0.6 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 1.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 6.6 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.2 | 1.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.8 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.2 | 1.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 0.7 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 0.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 3.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 0.6 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 0.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 0.7 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 0.9 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.2 | 3.8 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.2 | 0.7 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 0.9 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.2 | 0.7 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 1.6 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.2 | 1.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 0.4 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.2 | 0.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.2 | 1.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 5.8 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.2 | 0.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 0.2 | GO:0008193 | RNA guanylyltransferase activity(GO:0008192) tRNA guanylyltransferase activity(GO:0008193) guanylyltransferase activity(GO:0070568) |
0.2 | 0.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 4.8 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 0.4 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 0.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 1.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 0.7 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 1.6 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.2 | 0.5 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.2 | 0.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 0.9 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 5.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.2 | 7.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 1.0 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.2 | 1.5 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 0.7 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 0.8 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 0.8 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 0.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 0.5 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.2 | 2.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 1.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 0.5 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 1.3 | GO:0008759 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.2 | 0.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.2 | 3.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 0.7 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.2 | 0.8 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.8 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.2 | 0.3 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.2 | 1.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 0.5 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 1.9 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 0.5 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 0.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 2.4 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 1.9 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.2 | 0.5 | GO:0046428 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.2 | 0.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 1.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.5 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 0.8 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 0.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 2.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 2.0 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.2 | 0.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 1.2 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.1 | 1.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.4 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 2.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 1.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.4 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.1 | 3.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.9 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 8.4 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.7 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.7 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 1.3 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.1 | 2.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.7 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 2.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.1 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 0.4 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 2.4 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.7 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 1.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 0.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.4 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 1.7 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 0.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.1 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.1 | 0.7 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 0.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 0.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 1.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.6 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.8 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.1 | 0.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.9 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 4.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 1.0 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 1.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.4 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 1.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 1.8 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 1.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.4 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 0.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.5 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 1.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.4 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 1.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 23.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.6 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.1 | 0.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.6 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 1.5 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 6.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 0.7 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.2 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 0.1 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 3.7 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 2.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 1.8 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.2 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.1 | GO:0016436 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
0.1 | 0.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 2.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 1.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.6 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.1 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.9 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 1.5 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.2 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 7.8 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 1.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 4.3 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 2.6 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.2 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.1 | 0.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.8 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.4 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 0.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 0.3 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 3.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.9 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.4 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 4.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 1.1 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 0.3 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 5.7 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.1 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 1.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.8 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.3 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 3.1 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.1 | 1.3 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 1.4 | GO:0034792 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.1 | 0.5 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.1 | 1.8 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 0.4 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.5 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.3 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.6 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.5 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 10.3 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 0.9 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.4 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 1.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.6 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.1 | 0.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.3 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.3 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 1.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.3 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.6 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 0.3 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 0.1 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 1.0 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 2.6 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.1 | GO:0032138 | DNA insertion or deletion binding(GO:0032135) single base insertion or deletion binding(GO:0032138) |
0.1 | 0.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 3.5 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.4 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.2 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.7 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 2.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 2.1 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 0.8 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.5 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.5 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.1 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 1.8 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.1 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 5.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 1.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.1 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 0.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.7 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.6 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.1 | 0.3 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.1 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 1.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 1.1 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 3.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 1.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.6 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.7 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 1.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 1.0 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 1.3 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.6 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.1 | 0.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 7.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.6 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 1.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.4 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.2 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.1 | 0.4 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.3 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.1 | 1.8 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 1.0 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 3.0 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 4.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.3 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.1 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.0 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.0 | 1.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 1.6 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.2 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.0 | 1.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.7 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.2 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 0.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.1 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.2 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.0 | 0.1 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.0 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.5 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.6 | GO:0046332 | SMAD binding(GO:0046332) |
0.0 | 0.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.3 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.4 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.2 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.0 | 0.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 4.0 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.9 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.0 | 0.6 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.1 | GO:0030546 | receptor activator activity(GO:0030546) |
0.0 | 0.0 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 1.6 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 9.0 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) |
0.0 | 0.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 1.0 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.0 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.3 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 5.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.8 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 5.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.2 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.4 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.0 | 0.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.3 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.1 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.0 | GO:0051379 | epinephrine binding(GO:0051379) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.2 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.1 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 0.9 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.0 | 0.6 | GO:0052693 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.0 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.0 | 0.2 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0035240 | dopamine binding(GO:0035240) |
0.0 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.2 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.0 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.0 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.0 | 0.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.1 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.0 | 0.1 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 1.1 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.8 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.3 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.0 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 0.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.1 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.0 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.0 | 0.1 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.3 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.5 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.0 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.0 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.0 | GO:0070697 | activin receptor binding(GO:0070697) |
0.0 | 0.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.4 | GO:0016209 | antioxidant activity(GO:0016209) |
0.0 | 0.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.0 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 6.2 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.1 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.0 | 1.1 | GO:0019001 | guanyl nucleotide binding(GO:0019001) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.4 | 3.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 1.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 5.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.3 | 1.9 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 9.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 0.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.3 | 1.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 2.8 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.3 | 1.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 3.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 8.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 2.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 10.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 0.4 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 2.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 6.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 1.4 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 4.5 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 7.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 0.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 1.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 2.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 4.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 1.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 2.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 3.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 8.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 3.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 10.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 1.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 5.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 2.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 5.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 0.9 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 2.2 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 1.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.5 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 3.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 1.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 1.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 3.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 3.5 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.7 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 5.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 5.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 0.7 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 1.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 0.3 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 0.9 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 3.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.8 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 3.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 2.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 4.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 1.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 11.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.6 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.6 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 1.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.9 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.8 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.9 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.6 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 1.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 2.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 5.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 3.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 4.8 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.0 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 12.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.5 | 0.5 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.4 | 5.8 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.4 | 6.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.4 | 4.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.4 | 5.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.4 | 3.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 0.4 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.4 | 3.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.4 | 3.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 3.8 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.3 | 0.3 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.3 | 4.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 4.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 0.5 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.3 | 4.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.3 | 0.3 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.3 | 3.2 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.3 | 1.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 0.8 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 4.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 1.5 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 0.7 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 1.5 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.2 | 0.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 2.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 9.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 1.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 0.2 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.2 | 2.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 3.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 1.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 5.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 1.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 1.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 2.0 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 0.8 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.2 | 1.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 0.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 0.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 4.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 0.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 1.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 1.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 2.8 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.2 | 4.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 2.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 2.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 1.0 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 3.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 1.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 0.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 0.5 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 2.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 2.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 0.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 3.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 2.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 0.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 1.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 1.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 2.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 2.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 1.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 0.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 1.0 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.1 | 6.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 7.6 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 0.9 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 1.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 2.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 9.5 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 1.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 2.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 2.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.8 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 1.3 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 1.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.5 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 5.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 4.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 3.4 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.1 | 1.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 1.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 0.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 1.1 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.8 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 1.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.8 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 0.8 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.3 | REACTOME S PHASE | Genes involved in S Phase |
0.1 | 0.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.6 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 0.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 1.2 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 5.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.8 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 1.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 0.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.5 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 0.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 0.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 1.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.5 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 0.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.9 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 0.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.1 | REACTOME G1 S TRANSITION | Genes involved in G1/S Transition |
0.1 | 0.1 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
0.1 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 1.2 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 0.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 0.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.5 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 0.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 4.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 4.7 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 3.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.7 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.0 | 0.2 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.1 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 1.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 1.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.5 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.1 | REACTOME SIGNALLING TO ERKS | Genes involved in Signalling to ERKs |
0.0 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 1.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.1 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.2 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.0 | 1.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.1 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.0 | 1.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 2.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.1 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.9 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 1.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.2 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.0 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.0 | 0.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 1.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.0 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.0 | 0.5 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.0 | 0.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.0 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.9 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.0 | 0.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |